After Indiana Attorney General Todd Rokita used the announcement of the landmark $507 million opioid settlement to take a swipe at trial lawyers, one plaintiff’s attorney is hitting back, accusing the state’s top lawyer of nearly scuttling the deal that will be bringing much-needed funds to local Hoosier communities.
Naloxone vending machines designed to curb opioid overdose deaths
It took less than a week for Indiana’s first-ever naloxone vending machine to need a restock.Read More
DOC partnership provides Narcan kits to released inmates
In light of an increase of relapses and overdose numbers, the Indiana Department of Correction this month announced it would start offering naloxone, an agent used to reverse the effects of an opioid overdose, to every offender released from a DOC facility.Read More
CLE certifies attorneys to administer opioid overdose reversal drug
In addition to checking off two hours of CLE credit before the year’s end, attorneys who attended an Indianapolis Bar Association event earlier this month left certified to administer a life-saving drug. Lawyers learned how to properly use naloxone – commonly known by its brand name, Narcan – following a demonstration presented by the Indiana State Department of Health.Read More
‘Kid from a cornfield’: Goff brings community mentality to Supreme Court bench
He describes himself as “a kid from a cornfield.” And for Justice Christopher Goff, ties to his cornfield community run deep.Read More
Every city, town and county in Indiana is now participating in the $507 million opioid settlement with major pharmaceutical distributors and manufacturers, the Indiana Attorney General’s Office announced Wednesday.
More than 107,000 Americans died of drug overdoses last year, setting another tragic record in the nation’s escalating overdose epidemic, the Centers for Disease Control and Prevention estimated Wednesday.
Indianapolis and several other Indiana cities are joining an estimated $507 million statewide opioid settlement after previously opting out of the state’s lawsuits against opioid manufacturers and distributors.
Justice Department: State nursing board discriminated against nurses being treated for opioid use disorder
The Indiana State Board of Nursing is under fire from the U.S. Justice Department, which found that the board violated the Americans with Disabilities Act by prohibiting nurses who take medication to treat opioid use disorder from participating in a rehab program for nurses with substance abuse disorders.
For those who lost loved ones in the opioid crisis, making sure the family behind OxyContin maker Purdue Pharma paid a price was never just about money. What many wanted was a chance to confront the Sackler family face to face, to make them feel their pain. While some may get that chance — at least by video — under a tentative settlement reached Thursday that also would force the Sacklers to pay out billions, the families still are coming away feeling empty, conflicted and angry yet again.
In a case stemming from the opioid addiction crisis, the Supreme Court on Tuesday appeared ready to side with two imprisoned doctors who wrote thousands of prescriptions for pain medication in short periods.
Drugmaker Johnson & Johnson and three major distributors finalized nationwide settlements over their role in the opioid addiction crisis Friday, an announcement that clears the way for $26 billion to flow to nearly every state and local government in the U.S.
Thousands of towns across the United States are on the precipice of receiving billions of dollars in the second-biggest legal settlement in U.S. history. The $26 billion from three drug distributors and a pharmaceutical manufacturer would address damage wrought by opioids.
A jury’s finding this week that three major pharmacy chains are responsible for contributing to the scourge of opioid addiction in two Ohio counties may be just the beginning of a protracted legal battle that ultimately could leave the communities no better off.
An estimated 100,000 Americans died of drug overdoses in one year, a never-before-seen milestone that health officials say is tied to the COVID-19 pandemic and a more dangerous drug supply.
In a bellwether federal trial starting Monday in Cleveland, Ohio’s Lake and Trumbull counties will try to convince a jury that retail pharmacy companies played an outsized role in creating a public nuisance in the way they dispensed pain medication into their communities.
Four companies in the drug industry said Saturday that enough states had agreed to a settlement of lawsuits over the opioid crisis for them to move ahead with the $26 billion deal.
A federal bankruptcy judge gave conditional approval Wednesday to a sweeping settlement that will remove the Sackler family from ownership of OxyContin maker Purdue Pharma and devote potentially $10 billion to fighting the opioid crisis that has killed a half-million Americans over the past two decades.
Isolation, economic anxiety and fear of the coronavirus were dangerous fruits of the COVID-19 pandemic, particularly for individuals struggling with a substance use disorder, experts say. Bundled together, those factors made for a devastating year of increased drug overdose deaths that reached an all-time nationwide high.
The federal government is awarding Indiana more than $1 million to train workers in 25 counties to help deal with widespread opioid use, addiction and overdoses.
As a $26 billion settlement over the toll of opioids looms, some public health experts are citing the 1998 agreement with tobacco companies as a cautionary tale of runaway government spending and missed opportunities for saving more lives.
Indiana will receive $507 million as part of a multistate agreement to settle a lawsuit against opioid distributors designed to bring relief to people struggling with addiction to the drug, officials said Wednesday.
The three biggest U.S. drug distribution companies and the drugmaker Johnson & Johnson are on the verge of a $26 billion settlement covering thousands of government lawsuits over the toll of opioids across the U.S., a group of lawyers for local governments said Tuesday.
More than a dozen states have dropped their longstanding objections to OxyContin maker Purdue Pharma’s reorganization plan, edging the company closer to resolving its bankruptcy case and transforming itself into a new entity that helps combat the U.S. opioid epidemic through its own profits.